Log in or Sign up for Free to view tailored content for your specialty!
Lung Cancer News
‘We have the technology’: Telehealth increases access to palliative care for cancer
CHICAGO — Early palliative care via telehealth had an equivalent impact on quality of life as in-person visits for patients with advanced non-small cell lung cancer, according to study findings presented at ASCO Annual Meeting.
Lorlatinib produces ‘unprecedented’ disease progression delay in ALK-positive lung cancer
CHICAGO — Lorlatinib delivered never-before-seen PFS results in adults with anaplastic lymphoma kinase-positive non-small cell lung cancer, according to findings from a randomized phase 3 trial presented at ASCO Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants Retevmo accelerated approval for pediatric patients with thyroid cancer
The FDA granted accelerated approval to selpercatinib for the treatment of certain pediatric patients with metastatic or advanced solid tumors harboring RET alterations.
Patient-reported outcomes leveraged to overcome barriers to clinical trial enrollment
Participation in cancer-related clinical trials could increase dramatically if researchers screened and recruited individuals using routine care patient-reported outcomes, according to results published in JAMA Oncology.
Active cancer treatment linked to increased risk for sudden cardiac arrest
Active cancer treatment is associated with increased risk for sudden cardiac death, especially among patients younger than 74 years old and those with a history of heart failure, results from a retrospective study showed.
Health care professionals celebrate ‘milestone’ FDA approval for HER2-positive solid tumors
An analysis of global online conversations among health care professionals on social media in April revealed tremendous enthusiasm about FDA approval of a treatment for adults with advanced HER2-positive solid tumors.
Clinical trials may not offer ‘best management’ for cancer care
Patients participating in clinical trials for anticancer drugs do not gain a survival benefit compared with individuals who received routine care, according to study results published in JAMA.
‘We were shocked’: Vaping considerably increases lung cancer risk among people who smoke
People who vaped and smoked cigarettes appeared four times more likely to develop lung cancer compared with those who only smoked, according to study results presented at American Association for Cancer Research Annual Meeting.
NIH initiative to ‘rigorously evaluate’ benefits, harms of evolving cancer screening technologies
The prospect of screening for multiple cancer types simultaneously through a blood draw or other simple methods has generated tremendous excitement.
Immune-related toxicity from immune checkpoint inhibitors linked to longer survival
Certain individuals with non-cell lung cancer who experienced immune-related adverse events due to immune checkpoint inhibitor therapy had improved survival outcomes, according to retrospective study data published in JAMA Network Open.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read